RCG
GMED icon

Ruane, Cunniff & Goldfarb’s Globus Medical GMED Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Hold
6,008
– – 0.01% 37
2026
Q1 		$518K Buy
+6,008
New +$539K 0.01% 36

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's GMED Position: Q2 2026 in Review

Ruane, Cunniff & Goldfarb held its Globus Medical (GMED) position steady in Q2 2026 at 6,008 shares worth $475K. The position accounts for 0.01% of the portfolio, ranked #37.

Ruane, Cunniff & Goldfarb first reported a position in GMED in Q1 2026 and has held it in 2 quarters since. The position peaked at $518K in Q1 2026. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Ruane, Cunniff & Goldfarb held 6,008 shares of Globus Medical worth $475K as of Q2 2026.
  • Ruane, Cunniff & Goldfarb left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up 0.01% of Ruane, Cunniff & Goldfarb's portfolio in Q2 2026, its #37 holding.
  • Ruane, Cunniff & Goldfarb first reported a position in Globus Medical in Q1 2026 and has held it in 2 quarters since.
  • Ruane, Cunniff & Goldfarb's Globus Medical position peaked at $518K in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q2 2026, filed 14 Aug 2026.